Read today's eNewspaper

Patents, Copyrights and Trademarks

Maryland to receive $2.9 million in Cephalon settlement

Maryland to receive $2.9 million in Cephalon settlement

Maryland will receive $2.9 million as part of a multi-state settlement of claims that drugmaker Cephalon Inc. illegally blocked lower-cost alternatives to its popular wakefulness drug.

Maryland is among 48 states that will share a total of $125 million under the settlement, announced Thursday by Maryland Attorney General Brian Frosh.

The states' lawsuit alleged that Cephalon, worried about losing profits when the patent on its anti-sleep drug, Provigil, expired in 2006, sought to prevent other manufacturers from releasing generic versions of the drug.

Provigil is used to improve wakefulness among adults with sleep disorders, such as sleep apnea and narcolepsy.

In...

39°